200 related articles for article (PubMed ID: 8477194)
1. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Steube KG; Drexler HG
Leuk Lymphoma; 1993 Jan; 9(1-2):141-8. PubMed ID: 8477194
[TBL] [Abstract][Full Text] [Related]
2. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
Steube KG; Grunicke D; Quentmeier H; Drexler HG
Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
[TBL] [Abstract][Full Text] [Related]
3. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
4. Effects of bryostatin-5 and hematopoietic growth factors on acute myeloid leukemia cell differentiation, proliferation, and primary plating efficiency.
van der Hem KG; Dräger AM; Odding JH; Huijgens PC
Leuk Res; 1995 Sep; 19(9):651-7. PubMed ID: 7564476
[TBL] [Abstract][Full Text] [Related]
5. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL
J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
[TBL] [Abstract][Full Text] [Related]
6. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.
Jones RJ; Sharkis SJ; Miller CB; Rowinsky EK; Burke PJ; May WS
Blood; 1990 Mar; 75(6):1319-23. PubMed ID: 2310830
[TBL] [Abstract][Full Text] [Related]
7. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
[TBL] [Abstract][Full Text] [Related]
8. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
Steube KG; Grunicke D; Drexler HG
Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
[TBL] [Abstract][Full Text] [Related]
9. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
Grant S; Pettit GR; Howe C; McCrady C
Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.
Lilly M; Tompkins C; Brown C; Pettit G; Kraft A
Cancer Res; 1990 Sep; 50(17):5520-5. PubMed ID: 2386956
[TBL] [Abstract][Full Text] [Related]
11. Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: dose and time scheduling dependency.
van der Hem KG; Schuurhuis GJ; Dräger AM; Odding JH; Huijgens PC
Leuk Res; 1996 Sep; 20(9):743-50. PubMed ID: 8947584
[TBL] [Abstract][Full Text] [Related]
12. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4.
Hu ZB; Ma W; Uphoff CC; Lanotte M; Drexler HG
Leukemia; 1993 Nov; 7(11):1817-23. PubMed ID: 7901456
[TBL] [Abstract][Full Text] [Related]
13. Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells.
Stone RM; Sariban E; Pettit GR; Kufe DW
Blood; 1988 Jul; 72(1):208-13. PubMed ID: 2455568
[TBL] [Abstract][Full Text] [Related]
14. Varied differentiation responses of human leukemias to bryostatin 1.
Kraft AS; William F; Pettit GR; Lilly MB
Cancer Res; 1989 Mar; 49(5):1287-93. PubMed ID: 2917358
[TBL] [Abstract][Full Text] [Related]
15. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
17. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
18. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
[TBL] [Abstract][Full Text] [Related]
19. Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors.
Li Y; Mohammad RM; al-Katib A; Varterasian ML; Chen B
Leuk Res; 1997 May; 21(5):391-7. PubMed ID: 9225065
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]